|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 5/16 | (2006.01) |
| (11) | Number of the document | 2320940 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09807162.4 |
| Date of filing the European patent application | 2009-08-11 | |
| (97) | Date of publication of the European application | 2011-05-18 |
| (45) | Date of publication and mention of the grant of the patent | 2015-03-04 |
| (46) | Date of publication of the claims translation | 2015-06-25 |
| (86) | Number | PCT/US2009/053405 |
| Date | 2009-08-11 |
| (87) | Number | WO 2010/019570 |
| Date | 2010-02-18 |
| (30) | Number | Date | Country code |
| 188548 P | 2008-08-11 | US |
| (72) |
THUDIUM, Kent, B., US
KORMAN, Alan, J., US
LEBLANC, Heidi, US
YAMANAKA, Mark, US
SELBY, Mark, US
ZENS, Kyra, D., US
|
| (73) |
E. R. Squibb & Sons, L.L.C.,
Route 206 and Province Line Road, Princeton, NJ 08540,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Žmogaus antikūnai, kurie suriša limfocitų aktyvavimo geną-3, ir jų panaudojimas |
| HUMAN ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3), AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-07-03 | 17 | 347.00 EUR |
| 2026-08-11 |